Nicoletta B. De Cesare

Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

Kausik K Ray, Helen M Colhoun, Michael Szarek et al. · The Lancet Diabetes & Endocrinology · 2019 · 328 citations · Full text

Medicine, Cardiology, Internal Medicine +15

Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol

Gregory G. Schwartz, Vera A. Bittner, Patricio López‐Jaramillo et al. · Journal of the American College of Cardiology · 2021 · 141 citations · Full text

Medicine, Cardiology, Pharmacology +17

Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab

Emil Hagström, Philippe Gabríel Steg, Michael Szarek et al. · Circulation · 2022 · 122 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Relation of stenosis morphology and clinical presentation to the procedural results of directional coronary atherectomy.

Stephen G. Ellis, Nicoletta B. De Cesare, Cass A. Pinkerton et al. · Circulation · 1991 · 100 citations · Full text

Medicine, Cardiology, Surgery +17

Clinical, angiographic and procedural correlates of quantitative coronary dimensions after directional coronary atherectomy

Jeffrey J. Popma, Nicoletta B. De Cesare, Stephen G. Ellis et al. · Journal of the American College of Cardiology · 1991 · 50 citations

Medicine, Cardiology, Surgery +16